Login / Signup

Methotrexate for recurrent chronic rhinosinusitis with nasal polyps: A randomized, controlled, phase 2 clinical trial.

Aslı Çakır ÇetinYesim TuncokPembe KeskinogluMualla Aylin AriciFatos OnenMustafa Cenk Ecevit
Published in: International forum of allergy & rhinology (2022)
Low-dose MTX was a safe and effective maintenance therapy for patients with recurrent postoperative CRSwNPs.
Keyphrases
  • chronic rhinosinusitis
  • low dose
  • clinical trial
  • high dose
  • patients undergoing
  • open label
  • study protocol
  • randomized controlled trial